Greatdom Capsule PR contains a combination of Domperidone 30 mg and Pantoprazole 40 mg, formulated to manage gastrointestinal disorders involving acid reflux and delayed gastric emptying. Domperidone is a dopamine D2 receptor antagonist that enhances gastrointestinal motility by increasing the movement of the stomach and intestines, thereby facilitating gastric emptying and reducing symptoms such as nausea, vomiting, and bloating. Pantoprazole is a proton pump inhibitor that suppresses gastric acid secretion by inhibiting the H+/K+ ATPase enzyme system in the gastric parietal cells, effectively reducing gastric acidity and promoting mucosal healing in conditions like gastroesophageal reflux disease (GERD), erosive esophagitis, and peptic ulcers. The combination in Greatdom Capsule PR offers a synergistic effect by addressing both acid-related mucosal damage and impaired gastric motility. It is indicated for the treatment of GERD with associated motility disorders, functional dyspepsia, and other acid-related gastrointestinal conditions where delayed gastric emptying is a contributing factor. The prolonged-release formulation ensures sustained therapeutic plasma levels, improving patient compliance and symptom control. Greatdom Capsule PR should be used under medical supervision, with caution in patients with cardiac arrhythmias, liver impairment, or known hypersensitivity to its components.